Objective: In paediatric moderate-to-severe asthmatics, there is significant bronchospasm, airway obstruction, air trapping causing severe hyperinflation with more positive intraplural pressure preventing passive air movement. These effects cause an increased respiratory rate (RR), less airflow and shortened inspiratory breath time. In certain asthmatics, aerosols are ineffective due to their inadequate ventilation. Bilevel positive airway pressure (BiPAP) in acute paediatric asthmatics can be an effective treatment. BiPAP works by unloading fatigued inspiratory muscles, a direct bronchodilation effect, offsetting intrinsic PEEP and recruiting collapsed alveoli that reduces the patient's work of breathing and achieves their total lung capacity quicker. Unfortunately, paediatric emergency department (PED) BiPAP is underused and quality analysis is non-existent. A PED BiPAP Continuous Quality Improvement Program (CQIP) from 2005 to 2013 was evaluated using descriptive analytics for the primary outcomes of usage, safety, BiPAP settings, therapeutics and patient disposition.
Interventions: PED BiPAP CQIP descriptive analytics.
Setting: Academic PED.
Participants: 1157 patients.
Interventions: A PED BiPAP CQIP from 2005 to 2013 for the usage, safety, BiPAP settings, therapeutic response parameters and patient disposition was evaluated using descriptive analytics.
Primary And Secondary Outcomes: Safety, usage, compliance, therapeutic response parameters, BiPAP settings and patient disposition.
Results: 1157 patients had excellent compliance without complications. Only 6 (0.5%) BiPAP patients were intubated. BiPAP median settings: IPAP 18 (16,20) cm HO range 12-28; EPAP 8 cmHO (8,8) range 6-10; inspiratory-to-expiratory time (I:E) ratio 1.75 (1.5,1.75). Pediatric Asthma Severity score and RR decreased (p<0.001) while tidal volume increased (p<0.001). Patient disposition: 325 paediatric intensive care units (PICU), 832 wards, with 52 of these PED ward patients were discharged home with only 2 hours of PED BiPAP with no returning to the PED within 72 hours.
Conclusions: BiPAP is a safe and effective therapeutic option for paediatric patients with asthma presenting to a PED or emergency department. This BiPAP CQIP showed significant patient compliance, no complications, improved therapeutics times, very low intubations and decreased PICU admissions. CQIP analysis demonstrated that using a higher IPAP, low EPAP with longer I:E optimises the patient's BiPAP settings and showed a significant improvement in PAS, RR and tidal volume. BiPAP should be considered as an early treatment in the PED severe or non-responsive moderate asthmatics.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253518 | PMC |
| http://dx.doi.org/10.1136/bmjopen-2016-011845 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Management of COVID-19 in an adolescent demonstrates lasting effects of extreme prematurity on pulmonary function.
Respir Med Case Rep
March 2021
University of Massachusetts Children's Medical Center, Department of Pediatric Pulmonology, United States.
Article Synopsis
- Extremely premature infants have better survival rates due to advancements in care, but they may face long-term lung function issues.
- Clinicians must take into account their history of prematurity when treating these patients for COVID-19.
- A case study of a 17-year-old former preemie highlights the effective use of aggressive treatments to prevent severe respiratory complications during a SARS-CoV-2 infection, but more research is needed on this vulnerable population as they grow older.
Clinical factors associated with intubation in the high flow nasal cannula era.
Am J Emerg Med
December 2020
Department of Pediatrics, Section of Emergency Medicine, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, United States of America. Electronic address:
Background: Bronchiolitis is the most common cause for hospitalization in infants. While the use of high flow nasal cannula (HFNC) has increased, it has not uniformly reduced intubation rates.
Objective: We identified factors associated with respiratory failure in children with bronchiolitis on HFNC.
Paediatric ED BiPAP continuous quality improvement programme with patient analysis: 2005-2013.
BMJ Open
January 2017
Department of Pediatrics, University of Arkansas School of Medicine.
Objective: In paediatric moderate-to-severe asthmatics, there is significant bronchospasm, airway obstruction, air trapping causing severe hyperinflation with more positive intraplural pressure preventing passive air movement. These effects cause an increased respiratory rate (RR), less airflow and shortened inspiratory breath time. In certain asthmatics, aerosols are ineffective due to their inadequate ventilation.
View Article and Find Full Text PDFSafety and clinical findings of BiPAP utilization in children 20 kg or less for asthma exacerbations.
Intensive Care Med
August 2011
Department of Pediatrics, Division of Pediatric Emergency Medicine, Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville, USA.
Purpose: To investigate safety and clinical findings of bilevel positive airway pressure (BiPAP) utilization in children 20 kg or less for asthma exacerbations.
Methods: Retrospective and prospective descriptive analysis of 165 enrolled subjects with moderate and severe asthma exacerbations who weighed 20 kg or less and who received BiPAP treatment at a large, urban children's hospital pediatric emergency department (PED).
Results: Age was 0.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!